2025-05-05 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Report

This report analyzes Intuitive Surgical Inc., a company that manufactures and sells da Vinci surgical systems and related instruments and accessories.

**1) Performance vs. S&P 500 (VOO):**

Intuitive Surgical (ISRG) has significantly outperformed the S&P 500 (VOO) over the analyzed period.  The cumulative return for ISRG is 120.09%, while VOO's is 82.57%.  This results in a difference of 37.5 percentage points.  Considering the provided historical range of the relative divergence (from -14.2% to 112.2%), the current outperformance of ISRG relative to VOO sits at the 40.9th percentile.


| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 68.0% | 56.5% | 35.0% | -0.0 | 43.6 |
| 2016-2018  | 77.0% | 63.4% | 56.0% | -0.1 | 57.2 |
| 2017-2019  | 81.0% | 63.4% | 47.0% | 0.4 | 70.6 |
| 2018-2020  | 47.0% | 63.4% | 17.0% | 0.4 | 97.7 |
| 2019-2021  | 91.0% | 63.0% | 31.0% | 0.4 | 128.8 |
| 2020-2022  | -3.0% | 69.9% | -12.0% | 0.5 | 95.1 |
| 2021-2023  | -5.0% | 72.9% | -26.0% | 1.1 | 120.9 |
| 2022-2024  | 26.0% | 72.9% | 5.0% | 1.1 | 187.1 |
| 2023-2025  | 41.0% | 72.9% | 20.0% | 0.7 | 182.1 |

The table shows consistently high CAGR (Compound Annual Growth Rate) except for the recent periods (2020-2022 and 2021-2023), suggesting strong historical growth.  The fluctuating Alpha values indicate periods of both outperformance and underperformance relative to the market, while the Beta consistently above 1 demonstrates higher volatility than the market.


**2) Recent Price Movement:**

* **Closing Price:** $508.13
* **Last Market Price:** $529.42 (an increase of $2.37 from the previous close of $517.18). This represents a sharp upward movement.
* **5-day moving average:** $485.17
* **20-day moving average:** $487.88
* **60-day moving average:** $530.47

The price is currently above its 5-day and 20-day moving averages, suggesting short-term upward momentum.  However, it is slightly below its 60-day moving average, indicating potential resistance at that level.  The recent sharp increase should be noted.


**3) Technical Indicators:**

* **Market Risk Indicator (MRI):** 0.4053 (Medium Risk)
* **RSI:** 52.92 (Slightly above neutral; neither overbought nor oversold)
* **PPO:** 0.68 (Positive, suggesting upward momentum)
* **20-day Relative Divergence Change:** +4.0 (Short-term upward trend)
* **Expected Return:** 40.7% (Long-term, 2+ years, outperformance vs. S&P 500)

The indicators suggest a moderately bullish outlook. The recent price jump (as noted in the Last Market Price data) supports this short-term upward trend, but long-term investors should keep an eye on the RSI and potential resistance around the 60-day moving average.


**4) Recent Earnings Analysis:**

| Date       | EPS   | Revenue      |
|------------|-------|---------------|
| 2025-04-23 | 1.95  | $2.25B        |
| 2024-10-18 | 1.59  | $2.04B        |
| 2024-07-19 | 1.48  | $2.01B        |
| 2024-04-19 | 1.54  | $1.89B        |
| 2024-04-23 | 1.54  | $1.89B        | *(Note: Duplicate entry?)*

Earnings show some volatility, with a notable spike in EPS and revenue in the most recent quarter (2025-04-23).  Further investigation is needed to clarify the duplicate entry for 2024-04-23 and ensure data accuracy.


**5) Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-03-31 | $2.25B | 64.69%       |
| 2024-12-31 | $2.41B | 68.04%       |
| 2024-09-30 | $2.04B | 67.41%       |
| 2024-06-30 | $2.01B | 68.30%       |
| 2024-03-31 | $1.89B | 65.87%       |

Revenue shows some fluctuation but generally indicates strong performance. Profit margins are consistently high, demonstrating profitability.


**Capital and Profitability:**

| Quarter | Equity    | ROE     |
|---------|-----------|---------|
| 2025-03-31 | $17.11B  | 4.08%   |
| 2024-12-31 | $16.43B  | 4.17%   |
| 2024-09-30 | $15.58B  | 3.63%   |
| 2024-06-30 | $14.71B  | 3.58%   |
| 2024-03-31 | $13.96B  | 3.90%   |

Equity is steadily increasing, and ROE (Return on Equity), while fluctuating, remains positive. This suggests a healthy financial position.


**6) Overall Analysis:**

ISRG has demonstrated strong historical performance, significantly outperforming the S&P 500.  Recent price action indicates short-term upward momentum, but the price is nearing potential resistance.  Financial statements show consistent profitability and a strong financial position. While recent earnings have shown some volatility, the long-term outlook, supported by a high expected return, remains positive. However,  data discrepancies (duplicate entry) need clarification, and continued monitoring of key metrics is advisable before making any investment decisions.  The high Beta suggests higher risk compared to the overall market.
